Driehaus Capital Management LLC reported 354 equity positions with a combined reported value of $17.26B in its Q2 2026 Form 13F filing. The ten largest of those positions account for 16.3%of the filing’s reported value.
| # | Security | CUSIP | Class | Reported value | Shares | Weight |
|---|---|---|---|---|---|---|
| 1 | TSMC | 874039100 | ADR | $470.2M | 985K | 2.72% |
| 2 | Definium Therapeutics Inc | 24477V105 | COM | $322.0M | 6.85M | 1.87% |
| 3 | Praxis Precision Medicines Inc | 74006W207 | COM | $321.1M | 959K | 1.86% |
| 4 | Xenon Pharmaceuticals Inc | 98420N105 | COM | $266.7M | 4.42M | 1.55% |
| 5 | Silicon Motion Technology Corp | 82706C108 | ADR | $262.0M | 786K | 1.52% |
| 6 | Spyre Therapeutics Inc | 00773J202 | COM | $248.5M | 2.80M | 1.44% |
| 7 | Crinetics Pharmaceuticals Inc | 22663K107 | COM | $241.9M | 6.46M | 1.40% |
| 8 | Apogee Therapeutics Inc | 03770N101 | COM | $231.0M | 1.74M | 1.34% |
| 9 | Guardant Health Inc | 40131M109 | COM | $230.1M | 1.53M | 1.33% |
| 10 | Planet Labs PBC | 72703X106 | COM | $222.7M | 6.72M | 1.29% |
The full 354-position filing, quarter-over-quarter position changes, concentration analysis and cross-fund security search are in the Fund Tracker dashboard.
Open Fund TrackerRock Group holds Driehaus Capital Management LLC’s 13F filings for Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024. Period-over-period comparison — positions added, exited and resized — is available in the dashboard.
Browse all 13F filers on file, or read the Fund Tracker documentation for what Form 13F does and does not disclose.